Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Novel chiral phosphoric acid catalysis method offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing supply chain optimization and cost efficiency.
Patent CN113582873B reveals a green photocatalytic route for N-benzyl enamine using flavin catalysts. Discover cost-effective, scalable manufacturing solutions.
Patent CN106966901B enables green synthesis of lipoic acid intermediates with boron recycling. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104178469B reveals high-purity enzymatic route for Cilastatin intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.
Novel low-cost method for Cefmetazole Sodium via FeCl3 deprotection. High purity 92%, scalable route for antibiotic manufacturing.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.
Patent CN113861222A reveals a novel bimetallic catalyst for desoxytazobactam synthesis, offering higher yields and safer processing for API manufacturers.
Novel chiral preparation of bis-trifluoromethyl spiro oxindoles offers high yield and stereoselectivity for reliable pharmaceutical intermediates supplier scalability.
Advanced patent-based synthesis of Cefepime Hydrochloride using quaternary ammonium intermediates and phase transfer catalysis for superior purity and yield.
Novel quaternary ammonium salt intermediate method enhances yield and purity for cefepime manufacturing, offering cost-effective supply chain solutions.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.
Advanced nano-ruthenium catalytic hydrogenation for high-purity DCH18C6. Superior cis-isomer selectivity for nuclear waste treatment applications.
Patent CN109943582A reveals high-efficiency DDC catalysis for dopamine. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Novel amorphous nickel alloy catalysis for m-(β-hydroxyethylsulfone) aniline production offers high yield, reduced pollution, and extended catalyst life for dye manufacturers.
Novel one-step enzymatic route for L-carnosine reduces cost and complexity. Reliable supply chain partner for high-purity pharmaceutical intermediates and scalable production.
Patent CN103319483A reveals a green PTC-catalyzed route for Linagliptin intermediates, enabling solvent recovery and cost reduction in API manufacturing.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.